An interventional study of PRP and normal saline in PRP and Lateral Epicondylitis, sponsored by Beijing Jishuitan Hospital. Active, not recruiting at 1 site in China. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-05-28.
Sponsored by Beijing Jishuitan Hospital · Not applicable, Interventional, and Treatment
This study is a prospective randomized controlled study of different arthroscopic treatments for refractory external humeral epicondylitis combined with platelet rich plasma (PRP) injection. The patients with intractable external humeral epicondylitis were randomly divided into groups before the operation. After the arthroscopic operation was completed, they were divided into a local PRP injection group and a control group (normal saline) to perform additional operations on the damaged tendons, each for up to half a year after the operation. In different time periods, the quantitative and qualitative indicators including pain, functional score, muscle strength, MRI performance, etc. were compared between groups at the same time period to evaluate the difference in the effect of arthroscopic treatment combined with PRP on the treatment of damaged tendons. Determine the effectiveness of PRP. At the same time, in the process of arthroscopic treatment, look for risk factors that affect the curative effect of intractable external humeral epicondylitis, as well as the causes and prevention of common complications.
284 studies on the registry are indexed under Tennis Elbow; 60 are open to participants now.
This study's enrollment of 80 is above the median of 50 across 253 interventional studies indexed under Tennis Elbow.
Browse Tennis Elbow studies →Beijing Jishuitan Hospital is the lead sponsor of 43 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Arthroscopic treatment with PRP injection
Drug: PRP
Arthroscopic treatment with normal saline injection
Drug: normal saline
After the arthroscopic operation was completed, a local PRP with 4ml was injected
After the arthroscopic operation was completed, a local normal saline injection with same ml was performed
Mayo Elbow Performance Score
A score used to evaluated the elbow function, higher scores mean a better outcome.
Time frame: 3, 6 weeks and 3, 6, 12, 24 months postoperatively
Integrity of the tendon in MRI
MRI was performed to identify the status of the tendon
Time frame: 3, 6, 12, 24 months postoperatively
Disability of the Arm, Shoulder, and Hand (DASH)
A score used to evaluated the elbow function, higher scores mean a worse outcome.
Time frame: 3, 6 weeks and 3, 6, 12, 24months postoperatively
Patient-Rated Tennis Elbow Evaluation (PRTEE) scale
A score used to evaluated the elbow function, higher scores mean a worse outcome
Time frame: 3, 6 weeks and 3, 6, 12, 24months postoperatively
scoring system of Verhaar
A score used to evaluated the elbow function, higher scores mean a better outcome
Time frame: 3, 6 weeks and 3, 6, 12, 24months postoperatively
visual analog scale (VAS)
A score used to evaluated the elbow function, higher scores mean a better
Time frame: 3, 6 weeks and 3, 6, 12, 24months postoperatively
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Beijing Jishuitan Hospital